Cost–effectiveness of ticagrelor in acute coronary syndromes
M Henriksson, M Janzon - Expert review of pharmacoeconomics & …, 2013 - Taylor & Francis
Ticagrelor is a reversibly binding oral P2Y12 inhibitor, which belongs to a novel chemical
class of antiplatelet agents named cyclopentyl-triazolo-pyrimidines. Ticagrelor administered …
class of antiplatelet agents named cyclopentyl-triazolo-pyrimidines. Ticagrelor administered …